Analysis of clinical phenotype of a α2-globin gene mutation -IVS-Ⅱ-55 (T→G)
10.13602/j.cnki.jcls.2019.02.06
- VernacularTitle:α2珠蛋白基因突变IVS-Ⅱ-55(T→G)的临床表型分析
- Author:
Yumin LI
1
,
2
;
Yaqiong CHEN
1
,
2
;
Shuilan ZHANG
1
,
2
;
Lijuan KAN
1
,
2
;
Bing ZHANG
1
,
2
;
Huamei TANG
1
,
2
;
Xiuming ZHANG
1
,
2
Author Information
1. Department of Clinical Laboratory, Shenzhen Luohu District People&prime
2. s Hospital
- Publication Type:Journal Article
- Keywords:
α-thalassemia;
α-globin gene;
IVS-Ⅱ-55;
point mutation;
phenotype
- From:
Chinese Journal of Clinical Laboratory Science
2019;37(2):105-108
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify a α-globin gene mutation-IVS-Ⅱ-55 (T→A) and analyze hematological characteristics of IVS-Ⅱ-55 (T→G) carriers.
Methods:The peripheral blood samples were collected from the members of five family and three sporadic IVS-Ⅱ-55(T→G) carriers for the analysis of RBC parameters and hemoglobin electrophoresis. Gap-PCR, PCR-RDB (reverse dot blot) and DNA sequencing were carried out for the identification of gene deletion and mutation of α-globin and β-globin.
Results:The results of RBC parameters of five infant probands which presented with microcytic hypochromic anemia were below the normal reference interval. One of the adult carriers of IVS-Ⅱ-55 (T→G) heterozygote alone presented with microcytic hypochromic anemia, and the others showed normal RBC parameters. The hematological phenotype index (MCV, MCH and HbA 2 ) of one adult carrying a compound heterozygote for IVS-Ⅱ-55 (T→G) and βCD27-28M/N were 65.0 fL, 20.3 pg and 5.8% respectively. The hematological phenotype index (MCV, MCH, HbA 2 and HbF) of one adult carrying a compound heterozygote for IVS-Ⅱ-55 (T→G) and SEA-HPFH were 81.9 fL, 26.5 pg, 3.0% and 29.0% respectively. The HbA 2 levels of all carriers of IVS-Ⅱ-55 (T→G) heterozygote alone were in normal range. No abnormal hemoglobin band was detectable on hemoglobin electrophoresis for all the carries.
Conclusion:The carriers of IVS-Ⅱ-55(T→G) heterozygote alone were asymptomatic. The phenotype of compound heterozygote for β-thalassemia was similar to that of β-thalassemia alone.
- Full text:李育敏 主编审阅稿 20171181.doc